greeksoup/ stock research
Stock research / United States / TXG / Documents

10x Genomics, Inc. documents

10x Genomics (TXG) annual report: the 10-K filed 13 February 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 24 April 2026; latest 10-Q filed 7 August 2026 for the quarter ended 30 June 2026. Each links to the document on EDGAR, with 5 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
6 August 2026Results press release, exhibit 99 to the 8-K filed 6 August 2026The releaseEDGAR folder
7 May 2026Results press release, exhibit 99 to the 8-K filed 7 May 2026The releaseEDGAR folder
12 February 2026Results press release, exhibit 99 to the 8-K filed 12 February 2026The releaseEDGAR folder
12 January 2026Results press release, exhibit 99 to the 8-K filed 12 January 2026The releaseEDGAR folder
6 November 2025Results press release, exhibit 99 to the 8-K filed 6 November 2025The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
13 February 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
7 August 202610-Q, period ended 30 June 2026The documentEDGAR folder
8 May 202610-Q, period ended 31 March 2026The documentEDGAR folder
7 November 202510-Q, period ended 30 September 2025The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
24 April 2026DEF 14A, period ended 4 June 2026The documentEDGAR folder